a
ToolsRTI Biologics reported an 8 percent drop in first quarter revenue for 2013 when compared with 2012, due to weakness in the sports medicine, bone graft substitutes and the general orthopedic businesses.
SpineMark and the Royal National Orthopaedic Hospital in Stanmore, London, have developed a spine research unit within RNOH called Spinal Research Stanmore.
Medtronic has begun enrolling patients in its clinical trial for a back pain treatment device, according to the Memphis Business Journal.
The Food and Drug Administration granted 31 orthopedic- and spine-related clearances in March.
Princeton, N.J.-based Regentis Biomaterials has increased the number of sites in its clinical trial of the GelrinC tissue regeneration implant.
A new study shows female-specific knee implants may not improve outcomes in female total knee replacement patients, according to the American Academy of Orthopaedic Surgeons.
Princeton, N.J.-based Regentis Biomaterials received European CE Mark approval for the GelrinC biodegradable orthopedic implant.
Symmetry Medical released its Bookwalter Self-Retaining Rotilt Ratchet at the Congress of the Association of PeriOperative Registered Nurses in San Diego this week.
The FDA granted clearance to ArthroCare's SpeedLock HIP Knotless Fixation implant.
The US market for small bone and joint devices was valued at more than $2 billion in 2012, according to a Research and Markets report.
Page 2 of 36